Quintrio
Home

Stock overview

Ruanyun Edai Technology Inc. Ordinary shares

RYET

Ruanyun Edai Technology Inc is a data-driven artificial intelligence, or AI, technology company that focused on K-12 education in China. Campus & Education Services includes both historical school-facing products and services and newer Smart Campus Services, campus operations and student-life services, smart campus infrastructure, educational content, examination and assessment services, and AI vocational training. International Education & Testing includes HanLink and related language learning, testing, student recruitment and support services. AI Applications & Enterprise Solutions include Cogni AI, YeeZo and related document intelligence, workflow automation and AI application initiatives.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $0.441 – $0.498
Volume 7,426
Market cap $18M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for RYET.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for RYET.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

RYET Launches Co-Funded AI Script and Film Production Program on YeeZo

RYET announced a cooperation agreement through its subsidiary Jiangxi Ruanyun to develop approximately 400 AI-assisted scripts and 30 AI films over 12 months with a co-investor, each committing RMB 1 million. The program combines large language models with human writers and will distribute content internationally through Formind Global, with profits shared 60/40 between Jiangxi Ruanyun and the co-investor based on script sales, licensing, and platform revenue.

GlobeNewswire Inc.

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Ruanyun Edai Technology Inc. (NASDAQ: RYET) has signed a definitive agreement to grant BioNexus Gene Lab Corp. (NASDAQ: BGLC) an exclusive 10-20 year license for its Cogni AI document-intelligence platform in Malaysian healthcare. RYET will receive 560,000 BGLC shares and a 10% royalty on qualifying technology receipts. The deal aligns with Malaysia's RM1 billion healthcare digitalization initiative, though neither company has secured government contracts yet.

GlobeNewswire Inc.

Ruanyun Edai Technology Establishes Saudi Regional Headquarters, Accelerating Global Expansion, AI Education Deployment and Transition

Ruanyun Edai Technology Inc. (NASDAQ: RYET) announced the establishment of its Regional Headquarters in Saudi Arabia as part of its global expansion strategy and planned transition to Formind Group. The company expects approximately 10% revenue growth year-over-year for FY2026 (from $6.6M in FY2025) with significant revenue weighted toward the second half of the year. The Saudi RHQ will serve as a hub for AI-powered education solutions, Chinese language learning programs, and Smart Exam deployment across the MENA region.

GlobeNewswire Inc.

Ruanyun Edai Technology Announces Financial Results for Fiscal Year 2025

Chinese AI education technology company Ruanyun Edai reported a 27% revenue decrease to $6.7 million in FY2025, but improved gross margins and narrowed net losses through strategic shifts towards higher-margin software services and AI technologies.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.